V

E

VANDENDRIES , Erik

Last name: VANDENDRIES

First name: Erik

February 9, 2021 (v1)

Journal article

Metadata-only

Outcomes following hematopoietic stem cell transplantation in patients treated with standard chemotherapy with or without gemtuzumab ozogamicin for acute myeloid leukemia

Pautas, Cécile Raffoux, Emmanuel Lambert, Juliette

The phase 3 ALFA-0701 trial demonstrated improved outcomes with fractionated-dose gemtuzumab ozogamicin (GO) combined with standard chemotherapy vs. standard chemotherapy alone in adults with de novo acute myeloid leukemia (AML). We examined post-transplant outcomes and occurrence of hepatic veno-occlusive disease/sinusoidal obstruction...

Uploaded on: December 4, 2022